Literature DB >> 8976664

Validation of the reporting bases of the orthopaedic and paediatric surveillance schemes.

S Godward1, C Dezateux.   

Abstract

BACKGROUND: Nationally representative estimates of treatment rates for congenital dislocation of the hip were required to inform a review of the current United Kingdom screening policy. Cases were ascertained through an active reporting scheme involving orthopaedic surgeons and the existing British Paediatric Association Surveillance Unit (BPASU) scheme.
OBJECTIVE: To report the methods used to establish, maintain, and validate the orthopaedic and BPASU schemes.
METHODS: Multiple sources were used to develop the orthopaedic reporting base. Surgeons treating children were identified by postal questionnaire. The orthopaedic and paediatric reporting bases were compared to the 1992 manpower census surveys of surgeons and paediatricians.
RESULTS: A single source of respondent ascertainment would have missed 12% of the 517 surgeons who treated children. Comparison with the manpower census data suggests the orthopaedic and paediatric reporting bases were 97% and 92% complete.
CONCLUSIONS: Multiple sources should be used to establish and maintain a reporting base. Targeting respondents avoids unnecessary contact, saves resources, and may improve compliance. Manpower census data can be used for regular validation of the reporting base.

Entities:  

Mesh:

Year:  1996        PMID: 8976664      PMCID: PMC1511714          DOI: 10.1136/adc.75.3.232

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Diagnosing congenital dislocation of the hip.

Authors:  N M Clarke
Journal:  BMJ       Date:  1992-08-22

2.  Diagnosing congenital dislocation of the hip.

Authors:  P M Dunn
Journal:  BMJ       Date:  1992-10-10

3.  Screening for congenital dislocation of the hip.

Authors:  G C Bennet
Journal:  J Bone Joint Surg Br       Date:  1992-09

4.  The British Paediatric Surveillance Unit.

Authors:  S M Hall; M Glickman
Journal:  Arch Dis Child       Date:  1988-03       Impact factor: 3.791

5.  Assessing the human condition: capture-recapture techniques.

Authors:  R E Laporte
Journal:  BMJ       Date:  1994-01-01

6.  Evaluating the national screening programme for congenital dislocation of the hip.

Authors:  C Dezateux; S Godward
Journal:  J Med Screen       Date:  1995       Impact factor: 2.136

7.  Congenital dislocation of the hip: early and late diagnosis and management compared.

Authors:  P M Dunn; R E Evans; M J Thearle; H E Griffiths; P J Witherow
Journal:  Arch Dis Child       Date:  1985-05       Impact factor: 3.791

8.  Screening for HIV infection in pregnancy.

Authors:  C F Davison; F J Holland; M L Newell; C N Hudson; C S Peckham
Journal:  AIDS Care       Date:  1993

9.  Insulin dependent diabetes in children under 5: incidence and ascertainment validation for 1992.

Authors:  E Wadsworth; J Shield; L Hunt; D Baum
Journal:  BMJ       Date:  1995-03-18
  9 in total
  4 in total

1.  Evaluation of a national surveillance unit.

Authors:  M Gazarian; K Williams; E Elliott; K Chant; H Longbottom; C Mellis; T Nolan; R K Oates; A Ruben
Journal:  Arch Dis Child       Date:  1999-01       Impact factor: 3.791

2.  Rare disease surveillance: An international perspective.

Authors:  E J Elliott; A Nicoll; R Lynn; V Marchessault; R Hirasing; G Ridley
Journal:  Paediatr Child Health       Date:  2001-05       Impact factor: 2.253

3.  Neonatal meningitis in England and Wales: 10 years on.

Authors:  D E Holt; S Halket; J de Louvois; D Harvey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

4.  How to measure the need for transition to adult services among young people with Attention Deficit Hyperactivity Disorder (ADHD): a comparison of surveillance versus case note review methods.

Authors:  Helen Eke; Astrid Janssens; Johnny Downs; Richard M Lynn; Cornelius Ani; Tamsin Ford
Journal:  BMC Med Res Methodol       Date:  2019-08-20       Impact factor: 4.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.